Cargando…
Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells
VCAM-1 (CD106), a transmembrane glycoprotein, was first reported to play an important role in leukocyte adhesion, leukocyte transendothelial migration and cell activation by binding to integrin VLA-1 (α4β1). In the present study, we observed that VCAM-1 expression can be induced in many breast cance...
Autores principales: | Wang, Pei-Chen, Weng, Ching-Chieh, Hou, You-Syuan, Jian, Shu-Fang, Fang, Kuan-Te, Hou, Ming-Feng, Cheng, Kuang-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975354/ https://www.ncbi.nlm.nih.gov/pubmed/24583847 http://dx.doi.org/10.3390/ijms15033560 |
Ejemplares similares
-
A Role of CXCL1 Drives Osteosarcoma Lung Metastasis via VCAM-1 Production
por: Lee, Chiang-Wen, et al.
Publicado: (2021) -
Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.
por: Banks, R. E., et al.
Publicado: (1993) -
Modulation of VCAM-1 expression with antisense oligonucleotides targeting signalling molecules
por: Morel, J, et al.
Publicado: (2003) -
CD44-Targeting Oxygen Self-Sufficient Nanoparticles for Enhanced Photodynamic Therapy Against Malignant Melanoma
por: Hou, Xiaoyang, et al.
Publicado: (2020) -
Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease
por: Chen, Jian, et al.
Publicado: (2023)